Should combination therapy with inhaled corticosteroids and long-acting beta2-agonists be prescribed as initial maintenance treatment for asthma?
Lemière
Catherine
C
Service de pneumologie, Université de Montréal, Montreal, Que. lemierec@crhsc.umontreal.ca
Becker
Allan
A
Boulet
Louis-Philippe
LP
Bowie
Dennis
D
Cartier
André
A
Cockroft
Donald
D
Cowie
Robert
R
Ernst
Pierre
P
Fitzgerald
Mark
M
Sears
Malcolm
M
Spier
Sheldon
S
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D000420:Albuterol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000730:Androstadienes / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D000068297:Fluticasone-Salmeterol Drug Combination; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans
D000318:Adrenergic beta-Agonists; D000730:Androstadienes; D004338:Drug Combinations; D000068297:Fluticasone-Salmeterol Drug Combination; D005938:Glucocorticoids; D000420:Albuterol